Suppr超能文献

婴儿生长不良是否可能成为牛奶过敏的早期临床诊断标志物?

May Failure to Thrive in Infants Be a Clinical Marker for the Early Diagnosis of Cow's Milk Allergy?

机构信息

Department of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126 Bari, Italy.

Département de Pneumologie et Addictologie, Allergy Unit, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Univ Montpellier, 34000 Montpellier, France.

出版信息

Nutrients. 2020 Feb 13;12(2):466. doi: 10.3390/nu12020466.

Abstract

Objectives-Failure to thrive (FTT) in infants is characterized by growth failure. Although, cow's milk allergy (CMA) may have an impact on growth and leads to FTT, data are still limited. We focused on FTT as a possible clinical marker for an early diagnosis of CMA. The aim of the present study was to evaluate the implications of cow's milk hypersensitivity in infants with FTT and the growth catch-up after a cow's milk-free diet (CMFD). Methods-A cross-sectional study of all consecutive infants evaluated at the Pediatric Nutrition and Allergy Unit of the University Hospital of Bari (Italy) from January 2016 to April 2018 with a medical-driven diagnosis of FTT. Eligible infants were investigated for possible IgE mediated or non-IgE mediated CMA. Results-43 infants were included, mean age 5.7 months. 33/43 (77%) FTT presented a CMA related disease: 3/43 (7%) were diagnosed as presenting an IgE mediated CMA, 30 (93%) had a non IgE-mediated CMA, confirmed by the elimination diet for diagnostic purposes, that led to a significant improvement of symptoms and recrudescence after milk reintroduction. A total of 29 out of 30 patients (one patient was lost at follow-up) moved up to their original growth percentile after dietary changes. Growth z-scores were computed based on WHO anthropometric data. In 10 out of 43 patients (23%) were diagnosed with gastro-esophageal reflux disease (GERD). Conclusions-when evaluating an infant with FTT, physicians should include in their evaluation an extensive search for IgE mediated and non IgE mediated CMA. When in vivo and in vitro analysis are not conclusive, a 4- to 8-weeks trial of CMFD and a consecutive re-introduction of milk proteins may be helpful in less common diagnoses.

摘要

目的-婴儿生长不良(FTT)的特征是生长不良。尽管牛奶过敏(CMA)可能会影响生长并导致 FTT,但数据仍然有限。我们专注于 FTT 作为 CMA 早期诊断的可能临床标志物。本研究的目的是评估牛奶过敏对 FTT 婴儿的影响,以及无牛奶饮食(CMFD)后生长追赶的情况。方法-对 2016 年 1 月至 2018 年 4 月在意大利巴里大学医院儿科营养和过敏科就诊的所有连续婴儿进行了一项横断面研究,这些婴儿的诊断是由医学驱动的 FTT。对可能的 IgE 介导或非 IgE 介导 CMA 进行了研究。结果-共纳入 43 例婴儿,平均年龄为 5.7 个月。33/43(77%)FTT 存在与 CMA 相关的疾病:3/43(7%)被诊断为 IgE 介导的 CMA,30(93%)存在非 IgE 介导的 CMA,通过消除饮食进行诊断,在引入牛奶后症状显著改善并复发。共有 29/30 例患者(1 例患者在随访时丢失)在饮食改变后达到了原来的生长百分位。生长 z 评分基于世界卫生组织的人体测量数据计算。在 43 例患者中有 10 例(23%)被诊断为胃食管反流病(GERD)。结论-在评估 FTT 的婴儿时,医生应在评估中广泛寻找 IgE 介导和非 IgE 介导的 CMA。当体内和体外分析不明确时,4-8 周的 CMFD 试验和随后的牛奶蛋白重新引入可能有助于不常见的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf4/7071281/eac49c75f447/nutrients-12-00466-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验